02400nam a2200457 i 4500001001300000003000300013005001700016007001400033008004100047040003000088042000800118043001200126050002100138074001600159086002200175088008300197110014200280245031600422246006500738264006000803264010100863300002700964336002600991337002701017338003101044500003601075500002501111500002501136504004101161533010701202650002901309650001901338650001401357650004101371650003401412650004401446650003201490655003301522776019401555776019301749on1001342657BD20171216163643.0he bmb024bbca170818s2017    dcu     bb   f000 0 eng c  aPUCPRbengerdacGPOdMvI  apcc  an-us---14aKF27b.J874 2016  a1020-B (MF)0 aY 4.J 89/1:114-97  aSerial no. 114-97 (United States. Congress. House. Committee on the Judiciary)1 aUnited States.bCongress.bHouse.bCommittee on the Judiciary.bSubcommittee on Regulatory Reform, Commercial and Antitrust Law,eauthor.10aTreating the opioid epidemic :bthe state of competition in the markets for addiction medication : hearing before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law of the Committee on the Judiciary, House of Representatives, One Hundred Fourteenth Congress, second session, September 22, 2016.30aState of competition in the markets for addiction medication 1aWashington :bU.S. Government Publishing Office,c2017. 2aWashington, DC :bFor sale by the Superintendent of Documents, U.S. Government Publishing Office  aiv, 102 pages ;c24 cm  atextbtxt2rdacontent  amicroformbh2rdamedia  amicrofichebhe2rdacarrier  aShipping list no.: 2017-0061-M.  a"Serial No. 114-97."  aCRDP Program record.  aIncludes bibliographical references.  aMicrofiche.b[Washington, D.C.] :cU.S. Government Printing Office,d[2017]e2 microfiches : negative. 0aOpioid abusexTreatment. 0aBuprenorphine. 0aNaloxone. 0aPrescription pricingzUnited States. 0aDrugsxPriceszUnited States. 0aPharmaceutical industryzUnited States. 0aCompetitionzUnited States. 7aLegislative hearings.2lcgft08iOnline version:aUnited States. Congress. House. Committee on the Judiciary. Subcommittee on Regulatory Reform, Commercial and Antitrust Law.tTreating the opioid epidemicw(OCoLC)97209449108iPrint version:aUnited States. Congress. House. Committee on the Judiciary. Subcommittee on Regulatory Reform, Commercial and Antitrust Law.tTreating the opioid epidemicw(OCoLC)974374614